Analyst firms · Robert W. Baird · RPHM
Robert W. Baird RPHM price target and rating history
Reneo Pharmaceuticals Inc. (RPHM) · Health Care
Robert W. Baird rates Reneo Pharmaceuticals Inc. (RPHM) Neutral with a $3 price target, as of its latest action on Dec 14, 2023. It has published 3 rating actions on RPHM since January 2022, including 0 upgrades and 1 downgrade.
- Current rating
- Neutral
- Price target
- $3
- Median target, all firms
- Too few
- Actions on RPHM
- 3
Robert W. Baird price target on RPHM
Every Robert W. Baird rating on RPHM
- Dec 14, 2023
- Jan 27, 2022
- Jan 27, 2022
Questions about Robert W. Baird and RPHM
- What is Robert W. Baird's price target for RPHM?
- Robert W. Baird's latest stated price target for Reneo Pharmaceuticals Inc. (RPHM) is $3, from its action on Dec 14, 2023.
- What is Robert W. Baird's rating on RPHM?
- Robert W. Baird rates RPHM Neutral, a neutral rating, as of Dec 14, 2023.
- When did Robert W. Baird last change its view on RPHM?
- On Dec 14, 2023, Robert W. Baird downgrades to Neutral from Outperform, price target $28 to $3.
More RPHM rating histories
All Robert W. Baird ratingsRPHM news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.